Cargando…

Fecal Calprotectin for predicting Relapse and Activity in Patients with Crohn’s Disease: A Meta-analysis

AIMS: We aimed to perform a meta-analysis of the predictive capacity of fecal calprotectin (FC) in activity and relapse of Crohn’s disease (CD). MATERIALS AND METHODS: MEDLINE, EMBASE, and the Cochrane Library databases were searched systematically. Pooled sensitivity, specificity, and other diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuge, Ying, Huang, Qiu-Ping, Li, Qing, Wang, Jun-Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578578/ https://www.ncbi.nlm.nih.gov/pubmed/29201742 http://dx.doi.org/10.5005/jp-journals-10018-1182

Ejemplares similares

Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patients
por: Foster, Alice Jane, et al.
Publicado: (2019)

Can fecal calprotectin better stratify Crohn’s disease activity index?
por: Scaioli, Eleonora, et al.
Publicado: (2015)

Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn’s disease
por: Li, Junrong, et al.
Publicado: (2023)

Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease
por: Kennedy, Nicholas A., et al.
Publicado: (2019)

Effect of the Crohn’s Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn’s Disease
por: Matuszczyk, Małgorzata, et al.
Publicado: (2022)

Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis
por: Shi, Jin-Tong, et al.
Publicado: (2023)

Fecal calprotectin in predicting small bowel capsule endoscopy findings in pediatric patients with known Crohn’s disease
por: Wang, Shengnan, et al.
Publicado: (2022)

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
por: Kittanakom, Saranya, et al.
Publicado: (2017)

Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?
por: Romero-Mascarell, Cristina, et al.
Publicado: (2022)

Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis
por: Tham, Yuen Sau, et al.
Publicado: (2018)

Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity
por: Zittan, Eran, et al.
Publicado: (2018)

Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn’s disease
por: Somwaru, Alexander S., et al.
Publicado: (2019)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease
por: Gauss, Annika, et al.
Publicado: (2016)

Optimal Cutoff Level of Fecal Calprotectin for Detecting Small Bowel Inflammation in Crohn’s Disease
por: Kim, Eun Soo
Publicado: (2021)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease: Erratum
Publicado: (2016)

Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis
por: Li, Jiajia, et al.
Publicado: (2019)

Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
por: Paredes, José María, et al.
Publicado: (2022)

Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin
por: Zubin, Grover, et al.
Publicado: (2015)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

The role of fecal calprotectin in pediatric disease
por: Jeong, Su Jin
Publicado: (2019)

Clinical Value of Detecting Fecal Calprotectin by Using Colloidal Gold Assay in Screening or Diagnosing Crohn's Disease
por: Zhang, Wangdong, et al.
Publicado: (2023)

Fecal calprotectin reflects endoscopic activity in patients with small-bowel Crohn’s disease according to double-balloon endoscopy findings
por: Matsuura, Rinzaburo, et al.
Publicado: (2018)

Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases
por: Kan, Yee Man, et al.
Publicado: (2021)

Fecal Calprotectin is an Accurate Tool and Correlated to Seo Index in Prediction of Relapse in Iranian Patients With Ulcerative Colitis
por: Hosseini, Seyed Vahid, et al.
Publicado: (2015)

Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021)

Diagnostic Accuracy of Fecal Calprotectin for the Detection of Small Bowel Crohn’s Disease through Capsule Endoscopy: An Updated Meta-Analysis and Systematic Review
por: Jung, Eun Suk, et al.
Publicado: (2021)

Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis
por: Kolho, Kaija-Leena, et al.
Publicado: (2013)

The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
por: Lee, Yang Woon, et al.
Publicado: (2019)

Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review
por: Simon, Ebby George, et al.
Publicado: (2019)

Increased fecal calprotectin levels in Crohn’s disease correlate with elevated serum Th1- and Th17-associated cytokines
por: Bourgonje, Arno R., et al.
Publicado: (2018)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy
por: Hor, Jia Wei, et al.
Publicado: (2022)

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)

Can fecal calprotectin accurately identify histological activity of ulcerative colitis? A meta-analysis
por: Ye, Xiaoqi, et al.
Publicado: (2021)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao, Ying, et al.
Publicado: (2021)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
por: Kato, Jun, et al.
Publicado: (2016)

Fecal Calprotectin Assay at an Early Stage of Treatment Can Be Used as a Surrogate Marker to Predict Clinical Remission and Mucosal Healing in Pediatric Crohn’s Disease
por: Lee, Yeoun Joo, et al.
Publicado: (2022)

Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease
por: Crawford, Erin, et al.
Publicado: (2021)

Fecal calprotectin concentration in neonatal necrotizing enterocolitis
por: Yoon, Jung Min, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p8jq3gkpks7gfah58bphrjl153